The Hinge Moment: Artificial Intelligence, Human Data, and Drug Development in the 21st Century

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

Speakers:

Alicia Zhou CEOCancer Research Institute

Alicia Zhou

CEOCancer Research Institute

Janet Jin Exec Dir Precision Medicine Amgen

Janet Jin

Exec Dir Precision Medicine Amgen

Milad Alucozai Co-FounderRevalia Bio

Milad Alucozai

Co-FounderRevalia Bio

Tom Cassels Managing DirectorManatt Health

Tom Cassels

Managing DirectorManatt Health

About this Session:

AI is transforming how we understand and treat disease—not just by speeding up development, but by unlocking deeper insights into human biology through massive, diverse datasets. This panel will explore how life sciences companies are using AI, molecular engineering, and real-world data to advance precision medicine. From identifying the right treatments for the right patients to designing personalized therapies for complex and rare conditions, we’ll dive into what’s working today, where the science is heading, and what it means for patients in this new era of care.

Featured:

The Future of Value-Based Care: Scaling Beyond Pilots

AI in Healthcare: From Hype to Practical Impact

Featured:

The Art of the Possible: Redefining Healthcare with Agentic AI

New State Consumer Data Privacy Laws: Implications for Life Sciences and Medical Device Companies

Featured:

Real-time conversations with other healthcare innovators!

Build your network by connecting with other healthcare leaders.

Featured:

AI Is Causing a Mental Health Revolution—So Why Is it Failing Women?

From Bias to Breakthrough: Revolutionizing Rare Disease Diagnosis and Treatment for Women

HLTH 2025

Clinicians @ HLTH Series: Physicians of the Future: The Evolving Doctor Persona In an Era of Innovation

CTRL + ALT + CARE: Delivering Health That Works — Trusted, Proven, Connected

Global Health Connector – Joining Dots, Transforming Lives!

Affordability Isn’t an Option—It’s the Key to Survival!

The Bigger Picture: Scaling Personalized Medicine for All

KLAS Bridging the Divide: Payer Intelligence and Collaborations that Speed Care